ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 109 filers reported holding ANI PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $851 | +18.7% | 14,657 | +10.0% | 0.00% | 0.0% |
| Q2 2023 | $717 | +49.1% | 13,320 | +10.0% | 0.00% | +100.0% |
| Q1 2023 | $481 | -4.6% | 12,108 | -3.4% | 0.00% | 0.0% |
| Q4 2022 | $504 | -99.9% | 12,532 | +0.5% | 0.00% | 0.0% |
| Q3 2022 | $401,000 | +5.0% | 12,472 | -3.1% | 0.00% | 0.0% |
| Q2 2022 | $382,000 | +31.3% | 12,869 | +24.2% | 0.00% | 0.0% |
| Q1 2022 | $291,000 | -28.3% | 10,358 | +17.6% | 0.00% | 0.0% |
| Q4 2021 | $406,000 | +58.0% | 8,808 | +12.4% | 0.00% | 0.0% |
| Q3 2021 | $257,000 | -9.5% | 7,834 | -3.5% | 0.00% | 0.0% |
| Q2 2021 | $284,000 | -0.7% | 8,117 | +2.6% | 0.00% | 0.0% |
| Q1 2021 | $286,000 | +4.8% | 7,912 | -15.9% | 0.00% | 0.0% |
| Q4 2020 | $273,000 | +21.9% | 9,405 | +18.3% | 0.00% | 0.0% |
| Q3 2020 | $224,000 | -12.8% | 7,947 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $257,000 | -19.2% | 7,947 | +1.9% | 0.00% | 0.0% |
| Q1 2020 | $318,000 | -30.4% | 7,796 | +5.3% | 0.00% | 0.0% |
| Q4 2019 | $457,000 | -15.1% | 7,406 | +0.3% | 0.00% | -50.0% |
| Q3 2019 | $538,000 | +0.6% | 7,387 | +13.5% | 0.00% | 0.0% |
| Q2 2019 | $535,000 | +20.0% | 6,508 | +2.9% | 0.00% | +100.0% |
| Q1 2019 | $446,000 | +69.6% | 6,326 | +8.1% | 0.00% | 0.0% |
| Q4 2018 | $263,000 | -26.7% | 5,851 | -7.9% | 0.00% | 0.0% |
| Q3 2018 | $359,000 | -13.7% | 6,351 | +2.0% | 0.00% | 0.0% |
| Q2 2018 | $416,000 | +23.1% | 6,226 | +7.4% | 0.00% | 0.0% |
| Q1 2018 | $338,000 | -6.6% | 5,797 | +3.3% | 0.00% | 0.0% |
| Q4 2017 | $362,000 | +25.3% | 5,611 | +2.0% | 0.00% | 0.0% |
| Q3 2017 | $289,000 | +27.3% | 5,500 | +13.6% | 0.00% | 0.0% |
| Q2 2017 | $227,000 | +1.3% | 4,840 | +7.1% | 0.00% | 0.0% |
| Q1 2017 | $224,000 | -14.2% | 4,520 | +5.1% | 0.00% | 0.0% |
| Q4 2016 | $261,000 | -3.0% | 4,300 | +5.9% | 0.00% | 0.0% |
| Q3 2016 | $269,000 | +31.9% | 4,060 | +10.9% | 0.00% | 0.0% |
| Q2 2016 | $204,000 | – | 3,660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |